Last reviewed · How we verify

Placebo-matching Mifepristone — Competitive Intelligence Brief

Placebo-matching Mifepristone (Placebo-matching Mifepristone) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Glucocorticoid receptor antagonist. Area: Psychiatry / Neurology.

marketed Glucocorticoid receptor antagonist Glucocorticoid receptor (GR) Psychiatry / Neurology Small molecule Live · refreshed every 30 min

Target snapshot

Placebo-matching Mifepristone (Placebo-matching Mifepristone) — Roger K. Pitman, MD. Mifepristone is a glucocorticoid receptor antagonist that blocks cortisol signaling to modulate stress-related memory and emotional processing.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Placebo-matching Mifepristone TARGET Placebo-matching Mifepristone Roger K. Pitman, MD marketed Glucocorticoid receptor antagonist Glucocorticoid receptor (GR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Glucocorticoid receptor antagonist class)

  1. Quince Therapeutics S.p.A. · 1 drug in this class
  2. Roger K. Pitman, MD · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Placebo-matching Mifepristone — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-matching-mifepristone. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: